New hope for Tough-to-Treat lymphoma: trial tests Triple-Drug attack
NCT ID NCT05896163
Summary
This study is testing the safety and effectiveness of a new three-medicine combination for adults with an aggressive type of lymphoma (DLBCL) that has come back or stopped responding to prior treatments. The trial is for people who are not eligible for or do not want a stem cell transplant. Researchers will give all three drugs by IV infusion and monitor how patients respond to find the best dose of the newest medicine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allina Health Cancer Institute - Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
-
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
-
Barnes-Jewish Hospital Parkview Tower
St Louis, Missouri, 63110, United States
-
Hadassah Medical Center
Jerusalem, Jerusalem, 9112001, Israel
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Nagoya, Aichi-ken, 466-8650, Japan
-
Koo Foundation Sun Yat-Sen Cancer Center
Taipei, 112, Taiwan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, 811-1395, Japan
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
Princess Alexandra Hospital
Brisbane, Queensland, 4102, Australia
-
Rambam Health Care Campus
Haifa, Northern District, 3109601, Israel
-
Sheba Medical Center
Ramat Gan, Central District, 5262100, Israel
-
Shizuoka Cancer Center
Nagaizumi-cho, Shizuoka, 411-8777, Japan
-
Siteman Cancer Center
St Louis, Missouri, 63108, United States
-
Sourasky Medical Center
Tel Aviv, TELL ABĪB, 6423906, Israel
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
Swedish Medical Center
Seattle, Washington, 98122, United States
-
The University of Kansas Hospital
Kansas City, Kansas, 66160, United States
-
University of Kansas Hospital Cambridge North Tower A
Kansas City, Kansas, 66160, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.